Skip to main content
Equibles

Carlyle Group Inc.

Position in JSPR — Jasper Therapeutics, Inc.

CIK 1527166 WASHINGTON, DC
Back to JSPR Full portfolio

Position in JSPR

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$448,865
-$485,116 QoQ
Shares Held
1,066,189
0.0% QoQ
Ownership
3.20%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 44 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in JSPR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Carlyle Group Inc. holds $44,066,764 across 6 Biotechnology names. JSPR ranks #6 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PHAT
Phathom Pharmaceuticals, Inc.
 3,496,808 $37,940,366
2 SPRB
Spruce Biosciences, Inc.
 38,620 $2,085,480
3 ACET
Adicet Bio, Inc.
 184,295 $1,592,308
4 OKUR
OnKure Therapeutics, Inc.
 269,895 $1,230,721
5 QTTB
Q32 Bio Inc.
 60,363 $769,024
6 JSPR
Jasper Therapeutics, Inc.
This page 		1,066,189 $448,865

All Filings in JSPR

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $448,865 1,066,189
2026-03-31 $933,981 1,066,189
2025-12-31 $1,951,125 1,066,189
2025-09-30 $2,537,529 1,066,189
2025-06-30 $5,917,348 1,066,189
2025-03-31 $4,584,612 1,066,189
2024-12-31 $22,795,120 1,066,189
2024-09-30 $20,055,015 1,066,189
2024-06-30 $24,202,490 1,066,189
2024-03-31 $31,303,309 1,066,189
2023-12-31 $6,913,131 8,761,891
2023-09-30 $6,133,323 8,761,891
2023-06-30 $12,003,790 8,761,891
2023-03-31 $15,859,022 8,761,891